🇺🇸 FDA
Patent

US 11191761

SOMCL-9112 solid dispersion and preparation method thereof and SOMCL-9112 solid preparation containing SOMCL-9112 solid dispersion

granted A61KA61K31/502A61K47/10

Quick answer

US patent 11191761 (SOMCL-9112 solid dispersion and preparation method thereof and SOMCL-9112 solid preparation containing SOMCL-9112 solid dispersion) held by Shanghai Acebright Pharmaceuticals Group Co., Ltd. expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Shanghai Acebright Pharmaceuticals Group Co., Ltd.
Grant date
Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/502, A61K47/10, A61K47/32, A61K47/34